{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:12:40Z","timestamp":1790845960595,"version":"4.1.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,4]]},"DOI":"10.7759\/cureus.37130","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T20:31:37Z","timestamp":1680640297000},"source":"Crossref","is-referenced-by-count":1,"title":["Sonographic Diagnosis and Management With Delayed Hysterectomy of Two Cesarean Scar Pregnancies That Developed Into Placenta Percreta: Two Case Reports"],"prefix":"10.7759","author":[{"given":"Katherine T","family":"Huebner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eneka","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandria","family":"Weymon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh","family":"Seamon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mili","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Giuliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"C\u00f3rdoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.01.030","article-title":"Society for maternal-fetal medicine (SMFM) consult series #49: cesarean scar pregnancy","volume":"222","author":"Miller R","year":"2020","unstructured":"Miller R, Timor-Tritsch IE, Gyamfi-Bannerman C. Society for maternal-fetal medicine (SMFM) consult series #49: cesarean scar pregnancy. Am J Obstet Gynecol. 2020, 222:B2-B14. 10.1016\/j.ajog.2020.01.030","journal-title":"Am J Obstet Gynecol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/uog.17568","article-title":"Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta-analysis","volume":"51","author":"Cal\u00ec G","year":"2018","unstructured":"Cal\u00ec G, Timor-Tritsch IE, Palacios-Jaraquemada J, et al.. Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018, 51:169-75. 10.1002\/uog.17568","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogc.2019.07.009","article-title":"Cesarean scar pregnancy: diagnosis and pathogenesis","volume":"46","author":"Timor-Tritsch IE","year":"2019","unstructured":"Timor-Tritsch IE, Monteagudo A, Cal\u00ec G, D'Antonio F, Kaelin Agten A. Cesarean scar pregnancy: diagnosis and pathogenesis. Obstet Gynecol Clin North Am. 2019, 46:797-811. 10.1016\/j.ogc.2019.07.009","journal-title":"Obstet Gynecol Clin North Am"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56100496","article-title":"Cesarean scar pregnancy successfully managed to term: when the patient is determined to keep the pregnancy","volume":"56","author":"Kutlesic R","year":"2020","unstructured":"Kutlesic R, Kutlesic M, Vukomanovic P, Stefanovic M, Mostic-Stanisic D. Cesarean scar pregnancy successfully managed to term: when the patient is determined to keep the pregnancy. Medicina (Kaunas). 2020, 56:10.3390\/medicina56100496","journal-title":"Medicina (Kaunas)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2021.12.013","article-title":"Conservative management or cesarean hysterectomy for placenta accreta spectrum: the PACCRETA prospective study","volume":"226","author":"Sentilhes L","year":"2022","unstructured":"Sentilhes L, Seco A, Azria E, et al.. Conservative management or cesarean hysterectomy for placenta accreta spectrum: the PACCRETA prospective study. Am J Obstet Gynecol. 2022, 226:839.e1-839.e24. 10.1016\/j.ajog.2021.12.013","journal-title":"Am J Obstet Gynecol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.16647","article-title":"Clinical profiles of placenta accreta spectrum: the PACCRETA population-based study","volume":"128","author":"Kayem G","year":"2021","unstructured":"Kayem G, Seco A, Beucher G, et al.. Clinical profiles of placenta accreta spectrum: the PACCRETA population-based study. BJOG. 2021, 128:1646-55. 10.1111\/1471-0528.16647","journal-title":"BJOG"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2019.08.035","article-title":"Outcomes following a clinical algorithm allowing for delayed hysterectomy in the management of severe placenta accreta spectrum","volume":"222","author":"Zuckerwise LC","year":"2020","unstructured":"Zuckerwise LC, Craig AM, Newton JM, Zhao S, Bennett KA, Crispens MA. Outcomes following a clinical algorithm allowing for delayed hysterectomy in the management of severe placenta accreta spectrum. Am J Obstet Gynecol. 2020, 222:179.e1-9. 10.1016\/j.ajog.2019.08.035","journal-title":"Am J Obstet Gynecol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181d066d4","article-title":"Maternal outcome after conservative treatment of placenta accreta","volume":"115","author":"Sentilhes L","year":"2010","unstructured":"Sentilhes L, Ambroselli C, Kayem G, et al.. Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol. 2010, 115:526-34. 10.1097\/AOG.0b013e3181d066d4","journal-title":"Obstet Gynecol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.12411","article-title":"Conservative management of placenta percreta","volume":"140","author":"Matsuzaki S","year":"2018","unstructured":"Matsuzaki S, Yoshino K, Endo M, Kakigano A, Takiuchi T, Kimura T. Conservative management of placenta percreta. Int J Gynaecol Obstet. 2018, 140:299-306. 10.1002\/ijgo.12411","journal-title":"Int J Gynaecol Obstet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2019.02.054","article-title":"Evidence-based guidelines for the management of abnormally\u00a0invasive placenta: recommendations from the\u00a0International Society for Abnormally Invasive\u00a0Placenta","volume":"220","author":"Collins SL","year":"2019","unstructured":"Collins SL, Alemdar B, van Beekhuizen HJ, et al.. Evidence-based guidelines for the management of abnormally\u00a0invasive placenta: recommendations from the\u00a0International Society for Abnormally Invasive\u00a0Placenta. Am J Obstet Gynecol. 2019, 220:511-26. 10.1016\/j.ajog.2019.02.054","journal-title":"Am J Obstet Gynecol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2011.01.001","article-title":"Arteriovenous malformation identification after conservative management of placenta percreta with uterine artery embolization and adjunctive therapy","volume":"204","author":"Barber JT Jr","year":"2011","unstructured":"Barber JT Jr, Tressler TB, Willis GS, Martinez FJ, Peisner DB, Goodman JD, Taboada CD. Arteriovenous malformation identification after conservative management of placenta percreta with uterine artery embolization and adjunctive therapy. Am J Obstet Gynecol. 2011, 204:e4-8. 10.1016\/j.ajog.2011.01.001","journal-title":"Am J Obstet Gynecol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1586\/14737140.2015.1088786","article-title":"Optimal management of low-risk gestational trophoblastic neoplasia","volume":"15","author":"Goldstein DP","year":"2015","unstructured":"Goldstein DP, Berkowitz RS, Horowitz NS. Optimal management of low-risk gestational trophoblastic neoplasia. Expert Rev Anticancer Ther. 2015, 15:1293-304. 10.1586\/14737140.2015.1088786","journal-title":"Expert Rev Anticancer Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2019.03.005","article-title":"Can carboplatin or etoposide replace actinomycin-d for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia?","volume":"153","author":"Mora PA","year":"2019","unstructured":"Mora PA, Sun SY, Velarde GC, et al.. Can carboplatin or etoposide replace actinomycin-d for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia?. Gynecol Oncol. 2019, 153:277-85. 10.1016\/j.ygyno.2019.03.005","journal-title":"Gynecol Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/120385-sonographic-diagnosis-and-management-with-delayed-hysterectomy-of-two-cesarean-scar-pregnancies-that-developed-into-placenta-percreta-two-case-reports","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:56:05Z","timestamp":1707508565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/120385-sonographic-diagnosis-and-management-with-delayed-hysterectomy-of-two-cesarean-scar-pregnancies-that-developed-into-placenta-percreta-two-case-reports"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,4]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.37130","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,4]]}}}